BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32936729)

  • 21. Sex Difference in the Association of APOE4 with Memory Decline in Mild Cognitive Impairment.
    Wang X; Zhou W; Ye T; Lin X; Zhang J;
    J Alzheimers Dis; 2019; 69(4):1161-1169. PubMed ID: 31127771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered small-world anatomical networks in Apolipoprotein-E4 (ApoE4) carriers using MRI.
    Goryawala M; Zhou Q; Duara R; Loewenstein D; Cabrerizo M; Barker W; Adjouadi M
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():2468-71. PubMed ID: 25570490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration.
    Franzmeier N; Suárez-Calvet M; Frontzkowski L; Moore A; Hohman TJ; Morenas-Rodriguez E; Nuscher B; Shaw L; Trojanowski JQ; Dichgans M; Kleinberger G; Haass C; Ewers M;
    Mol Neurodegener; 2020 Oct; 15(1):57. PubMed ID: 33032659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aerobic exercise improves hippocampal blood flow for hypertensive Apolipoprotein E4 carriers.
    Kaufman CS; Honea RA; Pleen J; Lepping RJ; Watts A; Morris JK; Billinger SA; Burns JM; Vidoni ED
    J Cereb Blood Flow Metab; 2021 Aug; 41(8):2026-2037. PubMed ID: 33509035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in hippocampal volume during a preceding 10-year period do not correlate with cognitive performance and hippocampal blood‒brain barrier permeability in cognitively normal late-middle-aged men.
    Bakhtiari A; Vestergaard MB; Benedek K; Fagerlund B; Mortensen EL; Osler M; Lauritzen M; Larsson HBW; Lindberg U
    Geroscience; 2023 Apr; 45(2):1161-1175. PubMed ID: 36534276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
    Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
    Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic susceptibility in the deep gray matter may be modulated by apolipoprotein E4 and age with regional predilections: a quantitative susceptibility mapping study.
    Yim Y; Choi JD; Cho JH; Moon Y; Han SH; Moon WJ
    Neuroradiology; 2022 Jul; 64(7):1331-1342. PubMed ID: 34981175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment.
    Chung JK; Plitman E; Nakajima S; Chakravarty MM; Caravaggio F; Takeuchi H; Gerretsen P; Iwata Y; Patel R; Mulsant BH; Graff-Guerrero A
    J Alzheimers Dis; 2016; 49(3):743-54. PubMed ID: 26519442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein E genotype and physical function among older people with mild cognitive impairment.
    Doi T; Shimada H; Makizako H; Tsutsumimoto K; Uemura K; Suzuki T
    Geriatr Gerontol Int; 2015 Apr; 15(4):422-7. PubMed ID: 24730603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain Oxygen Extraction by Using MRI in Older Individuals: Relationship to Apolipoprotein E Genotype and Amyloid Burden.
    Lin Z; Sur S; Soldan A; Pettigrew C; Miller M; Oishi K; Bilgel M; Moghekar A; Pillai JJ; Albert M; Lu H
    Radiology; 2019 Jul; 292(1):140-148. PubMed ID: 31012816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced hippocampal volume in healthy young ApoE4 carriers: an MRI study.
    O'Dwyer L; Lamberton F; Matura S; Tanner C; Scheibe M; Miller J; Rujescu D; Prvulovic D; Hampel H
    PLoS One; 2012; 7(11):e48895. PubMed ID: 23152815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of MRI Biomarkers and Their Interactions with Cognitive Status and APOE ε4 in Nondemented Elderly Subjects.
    Liang X; Yin Z; Liu R; Zhao H; Wu S; Lu J; Qing Z; Wei Y; Yang Q; Zhu B; Xu Y; Zhang B
    Neurodegener Dis; 2018; 18(5-6):270-280. PubMed ID: 30673663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment.
    Blautzik J; Kotz S; Brendel M; Sauerbeck J; Vettermann F; Winter Y; Bartenstein P; Ishii K; Rominger A;
    J Alzheimers Dis; 2018; 65(3):781-791. PubMed ID: 28697560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of APOE ε4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment.
    Kim HJ; Ye BS; Yoon CW; Cho H; Noh Y; Kim GH; Choi YS; Kim JH; Jeon S; Lee JM; Kim JS; Choe YS; Lee KH; Kim ST; Kim C; Kang DR; Ki CS; Lee JH; Werring DJ; Weiner MW; Na DL; Seo SW
    Neurobiol Aging; 2013 Nov; 34(11):2482-7. PubMed ID: 23769398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.
    Belloy ME; Napolioni V; Han SS; Le Guen Y; Greicius MD;
    JAMA Neurol; 2020 Jul; 77(7):849-862. PubMed ID: 32282020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype.
    Haan MN; Aiello AE; West NA; Jagust WJ
    Neurobiol Aging; 2008 Dec; 29(12):1774-82. PubMed ID: 17540481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intellectual enrichment on AD biomarker trajectories: Longitudinal imaging study.
    Vemuri P; Lesnick TG; Przybelski SA; Knopman DS; Machulda M; Lowe VJ; Mielke MM; Roberts RO; Gunter JL; Senjem ML; Geda YE; Rocca WA; Petersen RC; Jack CR
    Neurology; 2016 Mar; 86(12):1128-35. PubMed ID: 26911640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deficits in spatial learning and memory is associated with hippocampal volume loss in aged apolipoprotein E4 mice.
    Yin JX; Turner GH; Lin HJ; Coons SW; Shi J
    J Alzheimers Dis; 2011; 27(1):89-98. PubMed ID: 21743131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke.
    Zerche M; Weissenborn K; Ott C; Dere E; Asif AR; Worthmann H; Hassouna I; Rentzsch K; Tryc AB; Dahm L; Steiner J; Binder L; Wiltfang J; Sirén AL; Stöcker W; Ehrenreich H
    Stroke; 2015 May; 46(5):1180-6. PubMed ID: 25765725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APOE-Sensitive Cholinergic Sprouting Compensates for Hippocampal Dysfunctions Due to Reduced Entorhinal Input.
    Bott JB; Héraud C; Cosquer B; Herbeaux K; Aubert J; Sartori M; Goutagny R; Mathis C
    J Neurosci; 2016 Oct; 36(40):10472-10486. PubMed ID: 27707979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.